300896 Stock Overview
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Imeik Technology Development Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥220.33 |
| 52 Week High | CN¥282.72 |
| 52 Week Low | CN¥132.81 |
| Beta | 1.38 |
| 11 Month Change | 59.35% |
| 3 Month Change | 29.64% |
| 1 Year Change | -13.90% |
| 33 Year Change | -50.33% |
| 5 Year Change | n/a |
| Change since IPO | 63.26% |
Recent News & Updates
Recent updates
Investors Appear Satisfied With Imeik Technology Development Co.,Ltd.'s (SZSE:300896) Prospects As Shares Rocket 43%
Sep 27
Are Investors Undervaluing Imeik Technology Development Co.,Ltd. (SZSE:300896) By 47%?
Jul 02Why Investors Shouldn't Be Surprised By Imeik Technology Development Co.,Ltd.'s (SZSE:300896) P/E
Feb 29Shareholder Returns
| 300896 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 4.2% | 1.7% | 2.7% |
| 1Y | -13.9% | -10.5% | 4.6% |
Return vs Industry: 300896 underperformed the CN Biotechs industry which returned -10.5% over the past year.
Return vs Market: 300896 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 300896 volatility | |
|---|---|
| 300896 Average Weekly Movement | 13.9% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 7.6% |
| 10% most volatile stocks in CN Market | 11.5% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 300896's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300896's weekly volatility has increased from 9% to 14% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 910 | Yifeng Shi | www.imeik.net/cn/ |
Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel.
Imeik Technology Development Co.,Ltd. Fundamentals Summary
| 300896 fundamental statistics | |
|---|---|
| Market cap | CN¥66.38b |
| Earnings (TTM) | CN¥2.02b |
| Revenue (TTM) | CN¥3.07b |
32.9x
P/E Ratio21.6x
P/S RatioIs 300896 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300896 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.07b |
| Cost of Revenue | CN¥158.10m |
| Gross Profit | CN¥2.91b |
| Other Expenses | CN¥892.69m |
| Earnings | CN¥2.02b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 24, 2024
| Earnings per share (EPS) | 6.69 |
| Gross Margin | 94.84% |
| Net Profit Margin | 65.74% |
| Debt/Equity Ratio | 0% |
How did 300896 perform over the long term?
See historical performance and comparison